| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.0058 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |